A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years

OBJECTIVE: The authors performed a randomised trial in very preterm small-for-gestational age (SGA) babies to determine if prophylaxis with granulocyte-macrophage colony-stimulating factor (GM-CSF) improves outcomes (the PROGRAMS trial). Despite increased neutrophil counts following GM-CSF, the auth...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlow, Neil, Morris, Timothy, Brocklehurst, Peter, Carr, Robert, Cowan, Frances M, Patel, Nishma, Petrou, Stavros, Redshaw, Maggie E, Modi, Neena, Dore, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533400/
https://www.ncbi.nlm.nih.gov/pubmed/22542709
http://dx.doi.org/10.1136/fetalneonatal-2011-301470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533400/
https://www.ncbi.nlm.nih.gov/pubmed/22542709
http://dx.doi.org/10.1136/fetalneonatal-2011-301470

Ejemplares similares